Gasoline was $1.15 per gallon, every toddler wanted a Teletubbies doll, and a startup called Google barely had anything online to search for. But in 1998 there were big changes on the horizon – many of them illustrated by a new technology that would become the genesis of Rapid Micro Biosystems.
Twenty-five years later, the forces that helped shape the 21st century still define our work at RMB: speed, digitalization, connectivity, automation. If you look at some milestones marking our journey in microbial quality control, you’ll sense a restless urgency to deliver new efficiencies for drug manufacturers and patients.
Commitment to evolve the Growth Direct® System has halved its footprint over the years while upgrading throughput, application set, LIMS integration, and ease of use.
Then and now, old and new: these themes still play out in microbial quality control, where rapid microbial methods (RMMs) are only beginning to overtake the manual practices developed by Robert Koch nearly 150 years ago.
Even though our customer base today includes over half of the top 20 largest pharmaceutical companies as measured by revenue, the great majority of firms have been slow to implement RMMs. It’s difficult to grasp how vast this industry is until you try to change it. But we still have that sense of urgency.
True to our origins, we’ve been busy at lab benches and whiteboards in pursuit of new innovations that can help customers deliver quality, cost-effective products in less time. In coming months, you can look for a major product announcement on our website or at one of our industry events.
So, stay tuned. The best is yet to come!